کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3355619 | 1217194 | 2012 | 8 صفحه PDF | دانلود رایگان |
We analyzed the epitope specificities of the polyclonal anti-C1q antibodies, present in human LN sera, searching to deduce the structural characteristics of C1q associated with its transition to an autoantigen. We screened 78 serum samples from LN patients distributed in three clinical groups – non-active, moderately active and severely active. We found three classes of C1q autoepitopes: (a) neo-epitopes, exposed upon immobilization due to conformational changes; (b) epitopes formed by sequences that are brought together by the conformation of the whole molecule; (c) cryptic epitopes that become exposed only after fragmentation of C1q. The latter suggest that the immunogen involved in the initiation of anti-C1q autoantibodies might be an extrinsic molecule that shares some degree of structural similarity to C1q. None of the tested epitope specificities was associated with active LN. We found a prevalence of anti-gC1q antibodies among the non-active LN patients suggesting that they might be the fraction of the polyclonal anti-C1q, preceding the initiation of autoimmunity to C1q, or alternatively, preceding LN flare.
► We found three classes of epitopes for the human anti-C1q autoantibodies.
► The majority of LN serum samples bound cryptic C1q autoepitopes.
► We found a higher degree of antigenicity for gC1q (42%) then CLR (13%).
► No correlation was found between active LN and any of the tested epitope specificities.
► The anti-gC1q prevail during non-active clinical status of LN.
Journal: Immunology Letters - Volume 148, Issue 1, November–December 2012, Pages 69–76